CBD Supplements: Opportunity or Barrier?

Want to get the latest on the TGA's proposal to down-schedule CBD? You're not alone! In our opinion, this is one of the most important developments to date for prescription cannabis in Australia.

The Take Friday Off Team had an opportunity last week to provide our perspective on the issue to the team at NutraIngredients.

This article is an excellent, balanced perspective with commentary from Carl Gibson and on behalf of Complementary Medicines Australia, the Therapeutic Goods Administration and some of the leading commercial players including Bod Australia Limited and MGC Pharmaceuticals Ltd. Sean Hall and the team at Medlab Clinical Ltd are also doing some great work in the space which is worth checking out too.

Like many of you, we will be very interested to see the outcome of the NZ Government Referendum later this year and will continue to stay across developments in Australia and across the world.